Sökresultat

LINJÄR ALGEBRA FMAB20 för F1 och Pi1, Ht1 2017 Kurschef Eskil Hansen, tel. 046–222 9628, e-post: eskil.hansen@na.lu.se. Mottagningstid: Enligt överenskommelse via mail i rum MH:562E. Övningsledare Eskil Hansen (F1.01–06) Viktor Larsson (F1.07–12, viktor.larsson@math.lth.se) Jacob Stordal Christiansen (Pi, jacob_stordal.christiansen@math.lth.se) Kurshemsida Föreläsningsanteckningar, kursplan och ny

https://www.maths.lu.se/fileadmin/maths/personal_staff/Eskil_Hansen/Kursprogram_FMAB20_FPi_2017ht.pdf - 2026-07-19

hacon.dvi Structural Mechanics OLA DAHLBLOM and JONAS LINDEMANN HACON A PROGRAM FOR SIMULATION OF TEMPERATURE AND STRESS IN HARDENING CONCRETE Detta är en tom sida! Copyright © 2000 by Structural Mechanics, LTH, Sweden. Printed by KFS i Lund AB, Lund, Sweden, May 2000. For information, address: Division of Structural Mechanics, LTH, Lund University, Box 118, SE-221 00 Lund, Sweden. Homepage: http:

https://www.byggmek.lth.se/fileadmin/byggnadsmekanik/publications/tvsm3000/web3057.pdf - 2026-07-19

Centrum för europaforskning har organiserat olika konferenser under åren. Här finner du en lista på rapporter från några av dessa konferenser. "In search for transcultural memory in Europe." Törnquist-Plewa, Barbara, Bernsand, Niklas & La Rosa, Marco (eds.). Från CFE:s COST-finansierade ISTME-nätverk i Memory Studies, 2012-2016.  Conference papers nr. 8 (PDF 3.52 MB, ny flik)   "Beyond transition?

https://www.cfe.lu.se/verksamhet/publikationer/conference-papers-series-aldre - 2026-07-19

Friday Cancer Centre Seminar Spring 2021 Friday Cancer Centre Seminar Spring 2021 Title Speaker Meeting room Strålbehandlingsavdelningen, kl 0815-0900 15-Jan Disparities in access to oncology clinical trials in Europe Ana Carneiro Föreläsningssalen 22-Jan No seminar 29-Jan Predictive markers for immunotherapy Göran B Jönsson Föreläsningssalen 5-Feb Genomic characterization of triple negative breas

https://www.lucc.lu.se/internal/sites/lucc.lu.se.internal/files/friday_cancer_centre_seminar_spring_2021_-_sheet1.pdf - 2026-07-20

https://www.ai.lu.se/start - 2026-07-19

IgA nephropathy (IgAN) and Henoch-Schönlein purpura (HSP) are diseases characterized by IgA deposits in the kidney and/or skin. Both may arise after upper respiratory tract infections, but the pathogenic mechanisms governing these diseases remain unclear. Patients with IgAN (n = 16) and HSP (n = 17) were included in this study aimed at examining whether IgA-binding M proteins of group A streptococ

Complement C2 deficiency (C2D) is associated with immunological diseases and increased susceptibility to invasive infections caused by encapsulated bacteria such as Neisseria menigitidis. In this study we evaluate the immunogenicity of vaccination against N. menigitidis in C2D. C2D patients (n=22) and controls (n=52) were given a tetravalent meningococcal polysaccharide vaccine. Serum bactericidal

Small synthetic ligands for protein purification have become increasingly interesting with the growing need for cheap chromatographic materials for protein purification and especially for the purification of monoclonal antibodies (mAbs). Today, Protein A-based chromatographic resins are the most commonly used capture step in mAb down stream processing; however, the use of Protein A chromatography

Background: Nigeria is a major contributor to the global malaria burden. The genetic diversity of malaria parasite populations as well as antibody responses of individuals in affected areas against antigens of the parasite can reveal the transmission intensity, a key information required to control the disease. This work was carried out to determine the allelic frequency of highly polymorphic Plas

https://www.ekonomiwebben.lu.se/sites/ekonomiwebben.lu.se/files/2026-06/Regleringsbrev-2026-Lunds-universitet-andringsbeslut-20260507.pdf - 2026-07-20

240919 Soc ia lhögskolan Socialhögskolans handlingsplan för jämställdhet och lika villkor 2024-2027 I föreliggande dokument beskrivs Socialhögskolans arbete med jämställdhet och lika villkor (JoL). Del 1 utgörs av handlingsplanen, dvs utgångspunkterna för institutionens JoL-arbete. Del 2 utgörs av planerade, pågående och avslutade åtgärder i enlighet med handlingsplanens målsättningar. JOL-arbetet

https://www.soch.lu.se/internt/sites/soch.lu.se.internt/files/2026-01/JoL%20Handlingsplan%202024-2027-2.pdf - 2026-07-20

Sheet1 Nr. Dnr Beslutsdatum 1 2009/658 12/17/09 2 2009/659 12/17/09 3 2010/383 1/20/11 4 2012/58 3/8/12 5 2012/379 8/9/12 6 2013/12 1/9/13 7 2013/459 9/19/13 8 2014/521 9/4/14 9 2014/681 10/30/14 10 2015/277 4/8/15 11 2015/522 8/20/15 12 2016/541 7/20/16 13 2016/742 9/29/16 14 2016/944 12/15/16 15 2017/88 2/2/17 16 2017/504 8/18/17 17 2017/875 11/9/17 18 2018/267 4/5/18 19 2019-00700 3/12/19 20 20

https://www.scan-b.lu.se/sites/scan-b.lu.se/files/2022-06/Etikgodk%C3%A4nnanden_20220613.xlsx - 2026-07-20

https://www.maths.lu.se/fileadmin/maths/Matematik_NF/Kursutvaerderingar/VT2024/MATA21VT24.pdf - 2026-07-18

Introduction: Severe asthma is a heterogeneous condition characterized by distinct phenotypes and endotypes based on clinical or biological characteristics. Interleukin (IL) 4 and IL-13 are central cytokines in the type 2 (T2) immune response, crucial for T2 inflammation. Biologic therapies targeting the IL-4/IL-13 pathway, such as anti-IL-4Rα monoclonal antibodies (mAbs), have shown improvements